Page 1 of 1INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.1. Company Name and Address4. EPA ProductRegistrationOMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460DATA CALL-IN RESPONSE3. Date and Type of DCI and NumberPRODUCT SPECIFIC11-Aug-2008ID # PDCI-107003-278772. Case # and Name3023 AzadioxabicyclooctaneChemical # and Name1070031H,3H,5H,-Oxazolo(3,4-c)oxazole, poly(oxymethylene)deriv.5. I wish tocancel thisproduct registration voluntarily6. Generic Data7. Product Specific Data7a. My product is an MUP andI agree to satisfy the MUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."7b. My product is an EUP andI agree to satisfy the EUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."6a. I am claiming a GenericData Exemption because Iobtain the active ingredientfrom the source EPA registration number listed below.6b. I agree to satisfy GenericData requirements as indicatedon the attached form entitled"Requirements Status andRegistrant's Response."N.A.N.A.N.A.N.A.10. Name of Company11. Phone Number9. Date8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.Signature and Title of Company's Authorized Representative__________________________________INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 1 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2008PDCI-107003-278772. Case # and Name3023 AzadioxabicyclooctaneEPA Reg. No. 1529-498. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321Product Chemistry Data Requirements (Antimicrobial)(1)830.15508K, X, OProduct Identity and composition(2)830.16008K, X, ODescription of materials used to produce the product(3)830.16208K, X, ODescription of production process(4)830.16508K, X, ODescription of formulation process(5)830.16708K, X, ODiscussion of formation of impurities(6 ,7 ,8)830.17008K, X, OPreliminary analysis(9)830.17508K, X, OCertified limits(10)830.18008K, X, OEnforcement analytical method(36)830.63028K, X, OColor(37)830.63038K, X, OPhysical state(38)830.63048K, X, OOdor12. Name of Company13. Phone NumberSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. Iacknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law11. DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 2 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2008PDCI-107003-278772. Case # and Name3023 AzadioxabicyclooctaneEPA Reg. No. 1529-498. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(11)830.63138K, X, OStability to sunlight, normal and elevatedtemperatures, metals, and metal ions(12 ,39)830.63148K, X, OOxidizing or reducing action(13 ,40)830.63158K, X, OFlammability(14 ,41)830.63168K, X, OExplodability830.63178K, X, OStorage stability of product(15 ,42)830.63198K, X, OMiscibility830.63208K, X, OCorrosion characteristics(16 ,43)830.63218K, X, ODielectric breakdown voltage(17 ,44)830.70008K, X, OpH of water solutions or suspensions830.70508K, X, OUV/Visible absorption(18 ,45)830.71008K, X, OViscosity(19 ,46)830.72008K, X, OMelting point/melting rangeInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 3 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2008PDCI-107003-278772. Case # and Name3023 AzadioxabicyclooctaneEPA Reg. No. 1529-498. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(20 ,47)830.72208K, X, OBoiling point/boiling range(21 ,48)830.73008K, X, ODensity/relative density(22 ,49)830.73708K, X, ODissociation constant in water(23)830.75508K, X, OPartition coefficient (n-octanol/water), shake flaskmethod(24)830.75708K, X, OPartition coefficient (n-octanol/water), estimation byliquid chromatography830.78408K, X, OWater solubility: Column elution method, shake flaskmethod830.78608K, X, OWater solubility, generator column method(50)830.79508K, X, OVapor pressureToxicology Data Requirements (Antimicrobial)(25 ,28)870.11008K, X, OAcute Oral Toxicity (do not select)(26 ,29 ,30)870.12008K, X, OAcute dermal toxicity(31 ,32)870.13008K, X, OAcute inhalation toxicityInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 4 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2008PDCI-107003-278772. Case # and Name3023 AzadioxabicyclooctaneEPA Reg. No. 1529-498. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(27 ,34 ,35)870.25008K, X, OAcute dermal irritation(33)870.24008K, X, OAcute eye irritationInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateCase # and Name:3023 AzadioxabicyclooctaneDCI Number:PDCI-107003-27877Page 1 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSUse Categories Key:K -O -X -ResidentialResidential Indoor useMaterials preservatives1Data must be provided in accordance with the "Product Composition" Section.(158.155)2Data must be provided in accordance with the "Description of Materials used to Produce the Product" Section.(158.160)3Data must be provided in accordance with the "Description of Production Process" Section.(158.162)4Data must be provided in accordance with the "Description of Formulation Process" Section.(158.165)5Data must be provided in accordance with the "Description of Formation of Impurities" Section(158.167)6If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).7Required for TGAIs and products produced by an integrated system.8Data must be provided in accordance with the "Preliminary Analysis" Section.(158.170)9Data must be provided in accordance with the "Certified Limits" Section(158.175)10Data must be provided in accordance with the "Enforcement Analytical Method" Section.(158.180)11Data on the stability to metals and metal ions is required only if the active ingredient is expected to come in contact with either material during storage.12Required if the product contains an oxidizing or reducing agent13Required when the product contains combustible liquids.14Required when the product is potentially explosive.15Required if the product is an emulsifiable liquid and is to be diluted with petroleum solvents.Case # and Name:3023 AzadioxabicyclooctaneDCI Number:PDCI-107003-27877Page 2 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSUse Categories Key:K -O -X -ResidentialResidential Indoor useMaterials preservatives16Required if the end-use product is a liquid and is to be used around electrical equipment.17Required if the product is dispersible with water.18Required if the product is a liquid.19Required when the TGAI is solid at room temperature.20Required if the TGAI is liquid at room temperature.21True density or specific density are required for all test substances. Data on bulk density is required for MPs that are solidat room temperature.22Required when the test substance contains an acid or base functionality (organic or inorganic) or an alcoholic functionality (organic).23Required if the TGAI or PAI is organic and non-polar.24Required if the TGAI or PAI is organic and non-polar.25Not required if test material is a gas or highly volatile.26Not required if test material is a gas or highly volatile.27Not required if test material is a gas or highly volatile.28For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution.29For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution.30Not required if test matierial is corrosive to skin or has pH < 2 or > 11.5; such a product will be classified as Toxicity Category I on the basis of potential eye & dermal irritation effects. (Note: Thiscondition triggers the caution word POISON on the product label.)Case # and Name:3023 AzadioxabicyclooctaneDCI Number:PDCI-107003-27877Page 3 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSUse Categories Key:K -O -X -ResidentialResidential Indoor useMaterials preservatives31Required when the product consists of, or under conditions of use will result in, an inhalable materia (e.g., gas, volatile substances, or aerosol/particulate.32For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution.33Not required if test matierial is corrosive to skin or has pH < 2 or > 11.5; such a product will be classified as Toxicity Category I on the basis of potential eye & dermal irritation effects. (Note: Thiscondition triggers the caution word POISON on the product label.)34Not required if test matierial is corrosive to skin or has pH < 2 or > 11.5; such a product will be classified as Toxicity Category I on the basis of potential eye & dermal irritation effects. (Note: Thiscondition triggers the caution word POISON on the product label.)35For the six acute studies conducted with the end-use product, the test must be conducted using the product as formulated for sale and distribution.36Required for TGAI and MUP but not for EUP.37Required for TGAI, MUP, and EUP.38Required for TGAI and MUP, but not for EUP.39Required for TGAI, MUP and EUP.40Required for MUP and EUP but not TGAI.41Required for MUP and EUP but not TGAI.42Required for MUP and EUP but not TGAI.43Required for EUP but not TGAI or MUP.44Required for TGAI, MUP, and EUP.45Required for MUP and EUP but not TGAI.Case # and Name:3023 AzadioxabicyclooctaneDCI Number:PDCI-107003-27877Page 4 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSUse Categories Key:K -O -X -ResidentialResidential Indoor useMaterials preservatives46Required for TGAI only.47Required for TGAI only.48Required for TGAI, MUP, and EUP.49Required for TGAI only.50Required for TGAI only.United States Environmental ProtectionAgency Washington, D.C. 20460LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICECo. Nr.Company NameAgent ForAddressCity & StateZipCase # and Name:3023,AzadioxabicyclooctaneINTERNATIONAL SPECIALTYPRODUCTS1361 ALPS RD.WAYNENJ074701529